CQA 206291: has antiparkinsonian activity as monotherapy, and as additional therapy in patients with insufficient response to levodopa
KeywordsLevodopa Orthostatic Hypotension Dopamine Agonist Evaluable Patient Additional Therapy
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
© Adis International Ltd 1990